Follow
Nicholas Han
Nicholas Han
Verified email at pennmedicine.upenn.edu
Title
Cited by
Cited by
Year
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
D Mathew, JR Giles, AE Baxter, DA Oldridge, AR Greenplate, JE Wu, ...
Science 369, 6508, 2020
16032020
Comprehensive mapping of immune perturbations associated with severe COVID-19
L Kuri-Cervantes, MB Pampena, W Meng, AM Rosenfeld, CAG Ittner, ...
Science immunology 5 (49), eabd7114, 2020
7962020
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
EM Bange, NA Han, P Wileyto, JY Kim, S Gouma, J Robinson, ...
Nature medicine 27 (7), 1280-1289, 2021
4422021
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
EM Anderson, EC Goodwin, A Verma, CP Arevalo, MJ Bolton, ME Weirick, ...
Cell 184 (7), 1858-1864. e10, 2021
4112021
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19
LA Vella, JR Giles, AE Baxter, DA Oldridge, C Diorio, L Kuri-Cervantes, ...
Science immunology 6 (57), eabf7570, 2021
2122021
SARS-CoV-2 seroprevalence among parturient women in Philadelphia
DD Flannery, S Gouma, MB Dhudasia, S Mukhopadhyay, MR Pfeifer, ...
Science immunology 5 (49), eabd5709, 2020
1482020
UPenn COVID Processing Unit, MR Betts, NJ Meyer, EJ Wherry, Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
D Mathew, JR Giles, AE Baxter, DA Oldridge, AR Greenplate, JE Wu, ...
Science 369 (6508), 2020
1112020
Cytomegalovirus latent infection is associated with an increased risk of COVID-19-related hospitalization
C Alanio, A Verma, D Mathew, S Gouma, G Liang, T Dunn, DA Oldridge, ...
The Journal of Infectious Diseases 226 (3), 463-473, 2022
542022
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer
EM Bange, NA Han, P Wileyto, JY Kim, S Gouma, J Robinson, ...
Research square, 2021
482021
Signaling through FcγRIIA and the C5a-C5aR pathway mediate platelet hyperactivation in COVID-19
SA Apostolidis, A Sarkar, HM Giannini, RR Goel, D Mathew, A Suzuki, ...
Frontiers in immunology 13, 834988, 2022
462022
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. medRxiv.[Europe PMC free article][Abstract][Google Scholar]
EM Anderson, EC Goodwin, A Verma, CP AREVALO, MJ BOLTON, ...
22020
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells
K Wang, P Coutifaris, D Brocks, G Wang, T Azar, S Solis, A Nandi, ...
Cancer Cell, 2024
2024
579-C Reinvigoration of progenitor-exhausted CD8 T cells by anti-CTLA-4 contributes to the sustained activity of combination checkpoint blockade
K Wang, P Coutifaris, D Brocks, S Solis, N Han, S Manne, E Kiner, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 2), 2023
2023
Final Results of a Phase I “RadVax” Trial of Hypofractionated Radiation Combined With Pembrolizumab in Patients With Metastatic Solid Tumors
JN Lukens, R Mick, AC Huang, N Han, MD Farwell, TC Mitchell, ...
International Journal of Radiation Oncology, Biology, Physics 111 (3), S67-S68, 2021
2021
Reinvigoration of Progenitor-Exhausted CD8 T Cells by anti-CTLA-4 Contributes to the Sustained Activity of Combination Checkpoint Blockade
K Wang, P Coutifaris, D Brocks, S Solis, N Han, S Manne, E Kiner, ...
The system can't perform the operation now. Try again later.
Articles 1–15